These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 37089116)

  • 21. Neutrophil-to-lymphocyte ratio as a prognostic biomarker for patients with locally advanced esophageal squamous cell carcinoma treated with definitive chemoradiotherapy.
    Zhou XL; Li YQ; Zhu WG; Yu CH; Song YQ; Wang WW; He DC; Tao GZ; Tong YS
    Sci Rep; 2017 Feb; 7():42581. PubMed ID: 28195186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preoperative systemic inflammation score (SIS) is superior to neutrophil to lymphocyte ratio (NLR) as a predicting indicator in patients with esophageal squamous cell carcinoma.
    Fu X; Li T; Dai Y; Li J
    BMC Cancer; 2019 Jul; 19(1):721. PubMed ID: 31331297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combining serum inflammation indexes at baseline and post treatment could predict pathological efficacy to anti‑PD‑1 combined with neoadjuvant chemotherapy in esophageal squamous cell carcinoma.
    Zhang X; Gari A; Li M; Chen J; Qu C; Zhang L; Chen J
    J Transl Med; 2022 Feb; 20(1):61. PubMed ID: 35109887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prognostic role of pre-treatment neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in esophageal squamous cell carcinoma treated with concurrent chemoradiotherapy.
    Man Q; Li P; Fan J; Yang S; Xing C; Bai Y; Hu M; Wang B; Zhang K
    BMC Cancer; 2024 Apr; 24(1):464. PubMed ID: 38616289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term efficacy and predictors of pembrolizumab-based regimens in patients with advanced esophageal cancer in the real world.
    Wang HC; Huang X; Chen J; Li Y; Cong Y; Qu BL; Feng SQ; Liu F
    World J Gastroenterol; 2023 Nov; 29(41):5641-5656. PubMed ID: 38077159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of systemic inflammatory and nutritional indexes in locally advanced gastric cancer treated with adjuvant chemoradiotherapy after D2 dissection.
    Wang SB; Chen JY; Xu C; Cao WG; Cai R; Cao L; Cai G
    Front Oncol; 2022; 12():1040495. PubMed ID: 36387250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymphocyte Nadir and Esophageal Cancer Survival Outcomes After Chemoradiation Therapy.
    Davuluri R; Jiang W; Fang P; Xu C; Komaki R; Gomez DR; Welsh J; Cox JD; Crane CH; Hsu CC; Lin SH
    Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):128-135. PubMed ID: 28816138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of esophageal cancer immune prognostic index in advanced esophageal squamous cell carcinoma patients with anti-programmed cell death-1 therapy.
    Lu J; Du L; Lei X; Zhang Z
    Cancer Med; 2023 May; 12(10):11334-11343. PubMed ID: 36951584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Benefit of chemotherapy based on platinum with definitive radiotherapy in older patients with locally advanced esophageal squamous cell carcinoma.
    Wu H; Yu Y; Zheng Q; Liu T; Wu Y; Wang Z; Zheng H; Liu L; Li J
    Radiat Oncol; 2021 Oct; 16(1):207. PubMed ID: 34717670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pretherapeutic systemic inflammation score is a prognostic predictor for elderly patients with oesophageal cancer: a case control study.
    Huang C; Wang M; Chen L; Wang H; Huang D; Shi J; Zhang W; Tian Y; Zhu Y
    BMC Cancer; 2023 Jun; 23(1):505. PubMed ID: 37270496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prognostic value of preoperative laboratory data indicators in patients with esophageal carcinoma: An observational study.
    Ma H; Liu Y; Ye H; Gao F; Li Z; Qin S
    Medicine (Baltimore); 2024 Jun; 103(24):e38477. PubMed ID: 38875403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphopenia During Definitive Chemoradiotherapy in Esophageal Squamous Cell Carcinoma: Association with Dosimetric Parameters and Patient Outcomes.
    Xu H; Lin M; Hu Y; Zhang L; Li Q; Zhu J; Wang S; Xi M
    Oncologist; 2021 Mar; 26(3):e425-e434. PubMed ID: 32960471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene expression analysis of pretreatment biopsies predicts the pathological response of esophageal squamous cell carcinomas to neo-chemoradiotherapy.
    Wen J; Yang H; Liu MZ; Luo KJ; Liu H; Hu Y; Zhang X; Lai RC; Lin T; Wang HY; Fu JH
    Ann Oncol; 2014 Sep; 25(9):1769-1774. PubMed ID: 24907633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High Preoperative Platelet to Lymphocyte Ratio Is Associated with a Greater Risk of Postoperative Complications and Hematogenous Recurrences in Esophageal Squamous Cell Carcinoma Patients Receiving Neoadjuvant Treatment.
    Sasahara M; Kanda M; Shimizu D; Takami H; Inokawa Y; Hattori N; Hayashi M; Tanaka C; Fujiwara M; Nakayama G; Kodera Y
    Dig Surg; 2023; 40(1-2):48-57. PubMed ID: 36893749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiRNA Expression Analysis of Pretreatment Biopsies Predicts the Pathological Response of Esophageal Squamous Cell Carcinomas to Neoadjuvant Chemoradiotherapy.
    Wen J; Luo K; Liu H; Liu S; Lin G; Hu Y; Zhang X; Wang G; Chen Y; Chen Z; Li Y; Lin T; Xie X; Liu M; Wang H; Yang H; Fu J
    Ann Surg; 2016 May; 263(5):942-8. PubMed ID: 26445467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemoradiation-induced changes in systemic inflammatory markers and their prognostic significance in oesophageal squamous cell carcinoma.
    Khin NS; Tan SH; Wang ML; Siow TR; Lim FL; Wang FQ; Ng MC; Lam JY; Yip C
    Br J Radiol; 2021 Jun; 94(1122):20200314. PubMed ID: 33861156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nomogram for predicting pathologic complete response to neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma.
    Liu G; Chen T; Zhang X; Hu B; Yu J
    Cancer Med; 2024 Mar; 13(5):e7075. PubMed ID: 38477511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of preoperative Nutritional Risk Screening-2002 combined with hematologic inflammatory markers on prognosis of thoracic esophageal squamous cell carcinoma].
    Guo XW; Zhu L; Ye HX; Zhou SB; Liu YC; Zhou JY; Ji SJ
    Zhonghua Zhong Liu Za Zhi; 2019 Aug; 41(8):604-609. PubMed ID: 31434452
    [No Abstract]   [Full Text] [Related]  

  • 39. Prognostic significance of preoperative lymphocyte-monocyte ratio in patients with resectable esophageal squamous cell carcinoma.
    Han LH; Jia YB; Song QX; Wang JB; Wang NN; Cheng YF
    Asian Pac J Cancer Prev; 2015; 16(6):2245-50. PubMed ID: 25824745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glasgow Prognostic Score as a Prognostic Clinical Marker in T4 Esophageal Squamous Cell Carcinoma.
    Ohira M; Kubo N; Masuda G; Yamashita Y; Sakurai K; Toyokawa T; Tanaka H; Muguruma K; Hirakawa K
    Anticancer Res; 2015 Sep; 35(9):4897-901. PubMed ID: 26254385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.